|
注册号: Registration number: |
ChiCTR1800015321 |
|
最近更新日期: Date of Last Refreshed on: |
2018-03-23 20:17:56 |
|
注册时间: Date of Registration: |
2018-03-23 00:00:00 |
|
注册号状态: |
预注册 |
|
Registration Status: |
Prospective registration |
|
注册题目: |
基于新一代靶向代谢组学技术的脓毒症感染源快速鉴定的研究 |
|
Public title: |
Rapid identification of septic infection pathogens based on the targeted metabolomics technology |
|
注册题目简写: |
|
|
English Acronym: |
|
|
研究课题的正式科学名称: |
基于新一代靶向代谢组学技术的脓毒症感染源快速鉴定的研究 |
|
Scientific title: |
Rapid identification of septic infection pathogens based on the targeted metabolomics technology |
|
研究课题代号(代码): Study subject ID: |
|
|
在二级注册机构或其它机构的注册号: The registration number of the Partner Registry or other register: |
|
申请注册联系人: |
王静 |
研究负责人: |
王静 |
|
Applicant: |
Jing Wang |
Study leader: |
Jing Wang |
|
申请注册联系人电话: Applicant telephone: |
+86 15668061566 |
研究负责人电话:
Study leader's |
+86 15668061566 |
|
申请注册联系人传真 : Applicant Fax: |
研究负责人传真: Study leader's fax: |
||
|
申请注册联系人电子邮件: Applicant E-mail: |
wangjinghehe@sina.com |
研究负责人电子邮件: Study leader's E-mail: |
wangjinghehe@sina.com |
|
申请单位网址(自愿提供): Applicant website(voluntary supply): |
研究负责人网址(自愿提供): Study leader's website(voluntary supply): |
||
|
申请注册联系人通讯地址: |
山东省烟台市芝罘区南通路1号 1-2-601 |
研究负责人通讯地址: |
山东省烟台市芝罘区南通路1号 1-2-601 |
|
Applicant address: |
Room 1-2-601, 1 Nantong Road, Zhifu District, Yantai, Shandong, China |
Study leader's address: |
Room 1-2-601, 1 Nantong Road, Zhifu District, Yantai, Shandong, China |
|
申请注册联系人邮政编码: Applicant postcode: |
研究负责人邮政编码: Study leader's postcode: |
||
|
申请人所在单位: |
烟台毓璜顶医院 |
||
|
Applicant's institution: |
Yantai Yu Huang Ding Hospital |
||
|
研究负责人所在单位: |
烟台毓璜顶医院 |
||
|
Affiliation of the Leader: |
Yantai Yu Huang Ding Hospital |
||
|
是否获伦理委员会批准: |
是 |
||
|
Approved by ethic committee: |
Yes |
||
|
伦理委员会批件文号: Approved No. of ethic committee: |
[2018]11 |
伦理委员会批件附件: Approved file of Ethical Committee: |
查看附件View |
|
批准本研究的伦理委员会名称: |
烟台毓璜顶医院医学伦理委员会 |
||
|
Name of the ethic committee: |
Medical ethics committee of Yantai Yuhuangding Hospital |
||
|
伦理委员会批准日期: Date of approved by ethic committee: |
2017-03-12 00:00:00 | ||
|
伦理委员会联系人: |
王璇 |
||
|
Contact Name of the ethic committee: |
Xuan Wang |
||
|
伦理委员会联系地址: |
山东省烟台毓璜顶医院医务处 |
||
|
Contact Address of the ethic committee: |
Yu Huang Ding Hospital, Medical Department, 1 Nantong Road, Zhifu District, Yantai, Shandong, China |
||
|
伦理委员会联系人电话: Contact phone of the ethic committee: |
伦理委员会联系人邮箱: Contact email of the ethic committee: |
||
|
研究实施负责(组长)单位: |
烟台毓璜顶医院 |
||||||||||||||||||||||
|
Primary sponsor: |
Yantai Yu Huang Ding Hospital |
||||||||||||||||||||||
|
研究实施负责(组长)单位地址: |
山东省烟台市芝罘区毓璜顶东路20号 |
||||||||||||||||||||||
|
Primary sponsor's address: |
20 Yuhuangding East Road, Zhifu District, Yantai, Shandong, China |
||||||||||||||||||||||
|
试验主办单位(项目批准或申办者): Secondary sponsor: |
|
||||||||||||||||||||||
|
经费或物资来源: |
山东省自然科学基金资助 |
||||||||||||||||||||||
|
Source(s) of funding: |
Shandong Natural Science Foundation |
||||||||||||||||||||||
|
研究疾病: |
脓毒症 |
||||||||||||||||||||||
|
Target disease: |
sepsis |
||||||||||||||||||||||
|
研究疾病代码: |
|
||||||||||||||||||||||
|
Target disease code: |
|
||||||||||||||||||||||
|
研究类型: |
57 |
||||||||||||||||||||||
|
Study type: |
57 |
||||||||||||||||||||||
|
研究所处阶段: |
探索性研究/预试验 | ||||||||||||||||||||||
|
Study phase: |
0 |
||||||||||||||||||||||
|
研究设计: |
队列研究 |
||||||||||||||||||||||
|
Study design: |
Cohort study |
||||||||||||||||||||||
|
研究目的: |
本研究选取ICU病房内收治的非脓毒症和脓毒症患者为研究对象,根据脓毒症感染源的不同分别入组。运用靶向代谢组学整合生物信息学分析各组患者体内代谢变化规律从系统生物学的角度,构建一个能早期、快速、有效诊断脓毒症感染类型的方案,初步筛选与脓毒症感染类型相关的可能生物标志物,以便早期采取积极措施改善脓毒症预后。 |
||||||||||||||||||||||
|
Objectives of Study: |
This study selected non sepsis and sepsis patients in ICU as the research object according to the different sources of sepsis. Using targeted metabolomics bioinformatics analysis of in vivo metabolism of patients in each group changes from a view of systems biology, build an early, rapid and effective diagnosis the scheme of sepsis, preliminary screening of type of infection may be associated with biomarkers of sepsis, early to take positive steps to improve the prognosis of sepsis. |
||||||||||||||||||||||
|
药物成份或治疗方案详述: |
|
||||||||||||||||||||||
|
Description for medicine or protocol of treatment in detail: |
|
||||||||||||||||||||||
|
纳入标准: |
|||||||||||||||||||||||
|
Inclusion criteria |
|||||||||||||||||||||||
|
排除标准: |
不能明确是否感染、ICU滞留时间小于72h、进行过心肺复苏、慢性肾功能不全、孕妇、临床资料不完整者。患者及家属自愿参加本项研究,经医院道德伦理委员会批准。 |
||||||||||||||||||||||
|
Exclusion criteria: |
Not clear whether infection, ICU retention time is less than 72h, CPR, chronic renal insufficiency, pregnant women, clinical data incomplete. The patients and their family members volunteered to participate in this study and approved by the hospital ethics committee. |
||||||||||||||||||||||
|
研究实施时间: Study execute time: |
从 From 2018-03-12 00:00:00至 To 2021-03-12 00:00:00 |
征募观察对象时间: Recruiting time: |
从 From 2018-03-13 00:00:00 至 To 2019-03-12 00:00:00 |
|
干预措施: Interventions: |
|
|
研究实施地点: Countries of recruitment and research settings: |
|
||||||||||||||||||||||||||||
|
测量指标: Outcomes: |
|
|
采集人体标本:
Collecting sample(s)
|
|
|
征募研究对象情况: Recruiting status: |
正在进行 Recruiting |
年龄范围: Participant age: |
|
||||||
|
性别: |
男女均可 |
Gender: |
Both |
||||||
|
随机方法(请说明由何人用什么方法产生随机序列): |
无 |
||||||||
|
Randomization Procedure (please state who generates the random number sequence and by what method): |
No |
||||||||
|
是否公开试验完成后的统计结果: Calculated Results after the Study Completed public access: |
公开/Public |
|
盲法: |
|
|
Blinding: |
|
|
试验完成后的统计结果(上传文件): |
|
|
Calculated Results after
|
|
|
是否共享原始数据: IPD sharing |
否No |
|
共享原始数据的方式(说明:请填入公开原始数据日期和方式,如采用网络平台,需填该网络平台名称和网址): |
2021.6 |
|
The way of sharing IPD”(include metadata and protocol, If use web-based public database, please provide the url): |
2021.6 |
|
数据采集和管理(说明:数据采集和管理由两部分组成,一为病例记录表(Case Record Form, CRF),二为电子采集和管理系统(Electronic Data Capture, EDC),如ResMan即为一种基于互联网的EDC: |
病例记录表 |
|
Data collection and Management (A standard data collection and management system include a CRF and an electronic data capture: |
standard data collection |
|
数据与安全监察委员会: Data and Safety Monitoring Committee: |
有/Yes |